Belite Bio stockBLTE
Belite Bio trades at $143.19, 28.4% below its 52-week high (Feb 3, 2026). The price is below its 50- and 200-day averages, a downtrend. −10.5% year to date, +27.4% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 17, 2026.
Ratings, candles, signals and the screener for BLTE — after you log in
Open the terminalFrequently asked questions about Belite Bio
What is the Belite Bio stock price?
At the close on Nov 5, 2026: $143.19 (−7.03% on the day). 52-week high: $200.00 on Feb 3, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Belite Bio report earnings?
The next quarterly report is on Nov 17, 2026. Last quarter, earnings per share changed −40% year over year, revenue 0%.
Does Belite Bio pay dividends?
No, Belite Bio does not pay dividends.
Where does Belite Bio trade and how to buy it?
Ticker BLTE, exchange Nasdaq, listed since 2022. You can buy it through a broker with access to US exchanges.
Should I buy Belite Bio now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for BLTE are in the terminal after you log in.